Get the Stockscreener App
6.09
4.10%
0.24
After Hours:
6.09
Profound Medical Corp Stock (PROF) Forecast
The Profound Medical Corp (PROF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $13.62, representing a +123.63% increase from the current price of $6.09. The highest analyst price target is $14.84, and the lowest is $12.40.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PROF Price Target
Average 19.32
(+217.17% Upside)
Is Profound Medical Corp (PROF) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.71 | Neutral |
| STOCH(9,6) | 13.63 | Buy |
| STOCHRSI(14) | 48.70 | Neutral |
| MACD(12,26) | -0.3765 | Sell |
| ADX(14) | 38.14 | Sell |
| William %R | -72.46 | Neutral |
| CCI(14) | -56.25 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.199
Sell
|
6.2542
Sell
|
| MA20 |
6.6905
Sell
|
6.5659
Sell
|
| MA50 |
7.2226
Sell
|
7.0556
Sell
|
| MA100 |
7.485
Sell
|
7.4708
Sell
|
| MA200 |
8.1034
Sell
|
7.917
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PROF could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on PROF, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.71 indicates that PROF is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 13.63 indicates that PROF is oversold. This indicates that PROF price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 48.7 indicates that PROF is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 38.14 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -56.25 indicates that PROF is still oversold but not to an extreme extent.
Long-term PROF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Profound Medical Corp financial reports and earnings history, Profound Medical Corp (PROF) stock could reach $10.88 by 2030, $12.20 by 2040 and $4.2168 by 2050. See the projected annual prices until 2050 of the Profound Medical Corp stock below:
- Profound Medical Corp (PROF) is expected to reach an average price of $5.3683 in 2035, with a high prediction of $6.3383 and a low estimate of $0.2624. This indicates an $-11.85% rise from the last recorded price of $6.09.
- Profound Medical Corp (PROF) stock is projected to chart a bullish course in 2040, with an average price target of $4.6648, representing an $-23.40% surge from its current level. The forecast ranges from a conservative $4.5248 to a sky-high $12.20.
- Our analysts predict Profound Medical Corp (PROF) to jump -59.34% by 2045, soaring from $0.0887 to an average price of $2.4763, potentially reaching $2.9553. While $0.0887 is the low estimate, the potential upside is significant.
- Profound Medical Corp (PROF) stock is expected to climb by 2050, reaching an average of $3.1455, a $-48.35% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.2168 and $4.2255, respectively, highlighting the market's uncertainty.
Profound Medical Corp Stock (PROF) Year by Year Forecast
Profound Medical Corp Stock (PROF) Price Forecast for 2025
Profound Medical Corp Stock (PROF) is expected to reach an average price of $18.28 in 2025, with a high prediction of $26.97 and a low estimate of $9.5856. This indicates an +200.15% rise from the last recorded price of $6.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $13.82 | $12.40 | $14.84 | +126.96% |
| April, 2025 | $12.33 | $11.66 | $14.09 | +102.47% |
| May, 2025 | $14.37 | $11.94 | $16.10 | +135.92% |
| June, 2025 | $14.86 | $14.37 | $17.01 | +144.08% |
| July, 2025 | $17.81 | $14.74 | $19.27 | +192.50% |
| August, 2025 | $19.00 | $15.49 | $21.13 | +212.00% |
| September, 2025 | $23.94 | $18.22 | $24.80 | +293.07% |
| October, 2025 | $20.04 | $19.03 | $26.97 | +229.01% |
| November, 2025 | $17.17 | $17.03 | $21.96 | +182.00% |
| December, 2025 | $17.21 | $16.54 | $18.92 | +182.64% |
Profound Medical Corp Stock (PROF) Price Forecast for 2026
The predicted value for Profound Medical Corp (PROF) in 2026 is set at an average of $12.23. Estimates vary from a peak of $18.75 to a trough of $5.7148, indicating an +100.83% surge from the present price of $6.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $16.75 | $14.03 | $18.75 | +175.04% |
| February, 2026 | $16.58 | $15.13 | $17.36 | +172.20% |
| March, 2026 | $15.59 | $13.81 | $17.04 | +156.06% |
| April, 2026 | $13.30 | $11.48 | $16.31 | +118.44% |
| May, 2026 | $13.62 | $11.78 | $14.40 | +123.64% |
| June, 2026 | $12.69 | $11.59 | $14.29 | +108.32% |
| July, 2026 | $11.59 | $10.93 | $13.41 | +90.24% |
| August, 2026 | $9.4028 | $9.1828 | $11.86 | +54.40% |
| September, 2026 | $9.7517 | $8.1099 | $10.36 | +60.13% |
| October, 2026 | $7.8188 | $7.3546 | $10.16 | +28.39% |
| November, 2026 | $7.2159 | $6.9673 | $8.3909 | +18.49% |
| December, 2026 | $6.4248 | $5.7148 | $9.037 | +5.50% |
Profound Medical Corp Stock (PROF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Profound Medical Corp (PROF) is $6.3387, with a high forecast of $11.40 and a low forecast of $1.2804. This indicates an +4.08% increase from the last price of $6.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.1119 | $6.0515 | $8.0683 | +16.78% |
| February, 2027 | $5.429 | $5.0791 | $7.2636 | -10.85% |
| March, 2027 | $7.4078 | $4.2225 | $7.6861 | +21.64% |
| April, 2027 | $5.7749 | $5.4535 | $7.8896 | -5.17% |
| May, 2027 | $5.662 | $4.932 | $5.8467 | -7.03% |
| June, 2027 | $5.7109 | $5.1188 | $7.8373 | -6.23% |
| July, 2027 | $3.568 | $3.428 | $5.7527 | -41.41% |
| August, 2027 | $2.0351 | $1.9751 | $3.8098 | -66.58% |
| September, 2027 | $2.8339 | $1.2804 | $3.0239 | -53.47% |
| October, 2027 | $2.951 | $2.691 | $3.5057 | -51.54% |
| November, 2027 | $8.3881 | $3.0928 | $8.8164 | +37.74% |
| December, 2027 | $10.96 | $7.9599 | $11.40 | +79.92% |
Profound Medical Corp Stock (PROF) Price Forecast for 2028
In 2028, Profound Medical Corp (PROF) is projected to reach an average price of $9.8026, with a high projection of $13.74 and a low estimate of $5.8673. This indicates an +60.96% rise from the last price of $6.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $10.96 | $9.9441 | $11.73 | +80.03% |
| February, 2028 | $8.7212 | $7.9562 | $11.68 | +43.21% |
| March, 2028 | $8.3301 | $6.7447 | $9.273 | +36.78% |
| April, 2028 | $12.07 | $8.2918 | $12.19 | +98.15% |
| May, 2028 | $13.06 | $9.6007 | $13.34 | +114.38% |
| June, 2028 | $11.19 | $10.31 | $13.74 | +83.80% |
| July, 2028 | $9.7102 | $9.5102 | $11.47 | +59.45% |
| August, 2028 | $7.1591 | $5.8673 | $9.507 | +17.55% |
| September, 2028 | $8.2862 | $6.0644 | $8.5162 | +36.06% |
| October, 2028 | $7.3582 | $7.2633 | $8.892 | +20.82% |
| November, 2028 | $8.9521 | $6.3268 | $8.9521 | +47.00% |
| December, 2028 | $8.3892 | $8.1957 | $9.9839 | +37.75% |
Profound Medical Corp Stock (PROF) Price Forecast for 2029
The 2029 price forecast for Profound Medical Corp Stock (PROF) is $9.3752 on average, with a high prediction of $16.40 and a low estimate of $2.3516. This represents an +53.94% increase from the previous price of $6.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.9081 | $5.4163 | $8.661 | -2.99% |
| February, 2029 | $6.8652 | $5.9199 | $7.8634 | +12.73% |
| March, 2029 | $7.5223 | $6.437 | $7.5813 | +23.52% |
| April, 2029 | $6.5794 | $5.7358 | $7.7409 | +8.04% |
| May, 2029 | $6.3683 | $5.6365 | $7.0129 | +4.57% |
| June, 2029 | $5.2985 | $5.091 | $6.49 | -13.00% |
| July, 2029 | $3.6077 | $3.3577 | $5.7171 | -40.76% |
| August, 2029 | $6.7255 | $3.4213 | $8.2619 | +10.43% |
| September, 2029 | $7.9197 | $5.5576 | $9.2761 | +30.04% |
| October, 2029 | $8.8574 | $7.5182 | $16.40 | +45.44% |
| November, 2029 | $5.2216 | $2.3516 | $10.60 | -14.26% |
| December, 2029 | $7.6758 | $4.8251 | $9.0678 | +26.04% |
Profound Medical Corp Stock (PROF) Price Forecast for 2030
Profound Medical Corp Stock (PROF) is expected to reach an average price of $15.95 in 2030, with a high forecast of $24.98 and a low forecast of $6.9171. This signifies an +161.85% surge from the last price of $6.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.4735 | $7.0493 | $10.88 | +39.14% |
| February, 2030 | $8.0277 | $6.9171 | $9.7377 | +31.82% |
| March, 2030 | $13.37 | $7.5213 | $13.88 | +119.57% |
| April, 2030 | $11.68 | $10.74 | $14.59 | +91.73% |
| May, 2030 | $10.61 | $10.00 | $12.48 | +74.28% |
| June, 2030 | $12.60 | $9.6174 | $13.98 | +106.86% |
| July, 2030 | $13.55 | $12.02 | $14.99 | +122.43% |
| August, 2030 | $14.54 | $12.71 | $15.44 | +138.75% |
| September, 2030 | $13.83 | $13.47 | $17.26 | +127.16% |
| October, 2030 | $21.02 | $13.76 | $21.19 | +245.19% |
| November, 2030 | $22.21 | $19.70 | $24.98 | +264.63% |
| December, 2030 | $19.21 | $16.77 | $22.87 | +215.44% |
0.38%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):